跳至主要内容
临床试验/NCT06629857
NCT06629857已完成不适用

Clinical Correlation of Alpha-Fetoprotein in Hepatocellular Carcinoma: a Cross-Sectional Study from Southeast Asia

Darul Sehat Hospital1 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2022年10月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
94
试验地点
1
主要终点
Mean Alpha-Fetoprotein (AFP) Levels in HCC Patients

研究概览

简要总结

This study aims to explore the levels of alpha-fetoprotein (AFP), a protein often elevated in liver cancer, in patients with hepatocellular carcinoma (HCC). The goal is to determine whether AFP levels vary based on the size of the liver tumor or other health conditions like hepatitis B, hepatitis C, and obesity. By analyzing data from 94 patients, the study seeks to identify factors that influence AFP levels, which may help in understanding liver cancer progression and improving diagnosis and treatment approaches.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
27 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 27 to 80 years.
  • Diagnosed with hepatocellular carcinoma (HCC) within the last three months.
  • Diagnosis confirmed by relevant investigations (e.g., imaging, liver biopsy).
  • Able to provide informed consent.

排除标准

  • Elevated alpha-fetoprotein levels due to tumors other than HCC.
  • Presence of secondary liver metastases from other primary sites.
  • Any significant comorbid conditions that could interfere with study assessments.
  • Pregnancy or breastfeeding.

结局指标

主要结局

Mean Alpha-Fetoprotein (AFP) Levels in HCC Patients

时间窗: Baseline measurement at time of diagnosis.

次要结局

  • Correlation Between AFP Levels and Tumor Size(At baseline (upon diagnosis).)

研究者

发起方
Darul Sehat Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maryam Abbasi

Principal investigator

Jinnah Sindh Medical University

研究点 (1)

Loading locations...

相似试验

A Cross Sectional Study Evaluating the Mean Levels... | 临床试验